Abivax Ratios (2021-2025) | ABVX

Ratios Dec2021 Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 33.89%-95.72%
EBT Margin -1,408,695,652.17%-65.01%944.00%-30.65%642.92%-89.34%465.14%88.49%-31.91%
EBIT Margin -1,408,695,652.17%-65.01%983.73%-27.93%584.27%-97.10%419.22%84.99%-16.79%
EBITDA Margin -1,408,695,652.17%-65.01%983.73%-27.93%584.27%-97.10%419.22%84.99%-16.79%
Operating Margin -1,408,695,652.17%-65.01%983.73%-27.93%584.27%-97.10%419.22%84.99%-16.79%
Net Margin -1,408,695,652.17%-65.01%944.00%-30.65%642.92%-89.34%465.14%88.49%-31.91%
FCF Margin 765.34%-39.86%411.91%-76.04%295.57%60.94%-14.83%
Efficiency
Assets Average 101.01M214.49M197.45M155.51M448.86M
Equity Average 197.45M155.51M448.86M
Invested Capital 70.45M50.81M415.44M309.04M408.18M349.13M316.62M775.52M
Asset Utilization Ratio 0.82-0.231.19
Leverage & Solvency
Debt to Equity 0.240.56
Debt Ratio 0.100.660.240.56175.60M135.43M762.28M
Equity Ratio 1.000.741.000.961.001.001.001.00
Valuation
Enterprise Value -69.44M-27.50M391.78M636.61M581.32M526.81M298.48M281.44M409.34M4,687.98M
Market Capitalization 672.74M899.08M831.92M724.99M460.67M395.92M485.15M5,386.06M
Return Ratios
Return on Sales -0.85%-0.86%-1.13%-1.23%5.89%-0.62%
Return on Capital Employed -2.19%-7.17%-0.68%
Return on Assets -1.01%-1.37%-0.74%
Return on Equity -1.01%-1.37%-0.74%